BC progression can be promoted by sustained exposure of estrogen and at least 70% of BCs are identified as estrogen receptor (ER)-positive luminal type whose development and growth are dependent on the estrogen-activated ERα (Whitworth et al., 2022). This evidence concerns the gene ESR1 and breast cancer.